These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21829457)

  • 1. Oxidative stress and inflammation in renal patients and healthy subjects.
    Lee DM; Jackson KW; Knowlton N; Wages J; Alaupovic P; Samuelsson O; Saeed A; Centola M; Attman PO
    PLoS One; 2011; 6(7):e22360. PubMed ID: 21829457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
    Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
    Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein particle abnormalities and the impaired lipolysis in renal insufficiency.
    Lee DM; Knight-Gibson C; Samuelsson O; Attman PO; Wang CS; Alaupovic P
    Kidney Int; 2002 Jan; 61(1):209-18. PubMed ID: 11786103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of fatty acids on apolipoprotein B secretion by human hepatoma cells (HEP G2).
    Arrol S; Mackness MI; Durrington PN
    Atherosclerosis; 2000 Jun; 150(2):255-64. PubMed ID: 10856517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased lipoprotein (a) and its relationships with other parameters of lipoprotein metabolism in chronic renal failure treated by hemodialysis.
    Yiğitoğlu MR; Polat MF; Akçay F; Ari Z; Uyanik BS; Ozilgili HM
    Jpn Heart J; 1997 Jan; 38(1):83-9. PubMed ID: 9186284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triglyceride-rich lipoproteins in chronic kidney disease patients undergoing maintenance haemodialysis treatment.
    Homma K; Homma Y; Yamaguchi S; Shiina Y; Wakino S; Hayashi K; Hori S; Itoh H
    Int J Clin Pract; 2012 Apr; 66(4):394-8. PubMed ID: 22420498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma concentrations of non-esterified fatty acids in chronic renal failure in the United Arab Emirates.
    Gillett MP; Obineche EN; Khan ST; Abdulle AM
    Saudi Med J; 2004 Nov; 25(11):1611-6. PubMed ID: 15573187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of 7-ketocholesterol in low density lipoprotein and fatty acid composition in erythrocyte membranes of patients on maintenance hemodialysis and healthy controls.
    Tsuzuki D; Sumino K; Yokoyama M
    Clin Chim Acta; 2000 May; 295(1-2):155-68. PubMed ID: 10767401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The compositional abnormalities of lipoproteins in diabetic renal failure.
    Attman PO; Knight-Gibson C; Tavella M; Samuelsson O; Alaupovic P
    Nephrol Dial Transplant; 1998 Nov; 13(11):2833-41. PubMed ID: 9829487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal lipid and apolipoprotein composition of major lipoprotein density classes in patients with chronic renal failure.
    Attman PO; Alaupovic P; Tavella M; Knight-Gibson C
    Nephrol Dial Transplant; 1996 Jan; 11(1):63-9. PubMed ID: 8649654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long term hemodialysis aggravates lipolytic activity reduction and very low density, low density lipoproteins composition in chronic renal failure patients.
    Mekki K; Prost J; Remaoun M; Belleville J; Bouchenak M
    BMC Cardiovasc Disord; 2009 Aug; 9():41. PubMed ID: 19709414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in lipoprotein composition in peritoneal dialysis patients.
    Moberly JB; Attman PO; Samuelsson O; Johansson AC; Knight-Gibson C; Alaupovic P
    Perit Dial Int; 2002; 22(2):220-8. PubMed ID: 11990407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein abnormalities in hyperlipidemic and normolipidemic men on hemodialysis with chronic renal failure.
    Sentí M; Romero R; Pedro-Botet J; Pelegrí A; Nogués X; Rubiés-Prat J
    Kidney Int; 1992 May; 41(5):1394-9. PubMed ID: 1614054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining beta-adrenergic and peroxisome proliferator-activated receptor gamma stimulation improves lipoprotein composition in healthy moderately obese subjects.
    Hughes TA; Stentz F; Gettys T; Smith SR
    Metabolism; 2006 Jan; 55(1):26-34. PubMed ID: 16324916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effects of cis and trans monounsaturated (18:1) and saturated (16:0) fatty acids on the synthesis and secretion of apolipoprotein A-I- and apolipoprotein B-containing lipoproteins in HepG2 cells.
    Dashti N; Feng Q; Franklin FA
    J Lipid Res; 2000 Dec; 41(12):1980-90. PubMed ID: 11108731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid and apolipoprotein profiles of uremic dyslipoproteinemia--relation to renal function and dialysis.
    Attman PO; Alaupovic P
    Nephron; 1991; 57(4):401-10. PubMed ID: 2046821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesteryl ester transfer activity in liver disease and cholestasis, and its relation with fatty acid composition of lipoprotein lipids.
    Iglesias A; Arranz M; Alvarez JJ; Perales J; Villar J; Herrera E; Lasunción MA
    Clin Chim Acta; 1996 Apr; 248(2):157-74. PubMed ID: 8740580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between plasma phospholipid saturated fatty acids and metabolic markers of lipid, hepatic, inflammation and glycaemic pathways in eight European countries: a cross-sectional analysis in the EPIC-InterAct study.
    Zheng JS; Sharp SJ; Imamura F; Koulman A; Schulze MB; Ye Z; Griffin J; Guevara M; Huerta JM; Kröger J; Sluijs I; Agudo A; Barricarte A; Boeing H; Colorado-Yohar S; Dow C; Dorronsoro M; Dinesen PT; Fagherazzi G; Franks PW; Feskens EJM; Kühn T; Katzke VA; Key TJ; Khaw KT; de Magistris MS; Mancini FR; Molina-Portillo E; Nilsson PM; Olsen A; Overvad K; Palli D; Quirós JR; Rolandsson O; Ricceri F; Spijkerman AMW; Slimani N; Tagliabue G; Tjonneland A; Tumino R; van der Schouw YT; Langenberg C; Riboli E; Forouhi NG; Wareham NJ
    BMC Med; 2017 Nov; 15(1):203. PubMed ID: 29145892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation and oxidative stress in end-stage renal disease patients treated with hemodialysis or peritoneal dialysis.
    Filiopoulos V; Hadjiyannakos D; Takouli L; Metaxaki P; Sideris V; Vlassopoulos D
    Int J Artif Organs; 2009 Dec; 32(12):872-82. PubMed ID: 20037892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma apolipoprotein C-III metabolism in patients with chronic kidney disease.
    Ooi EM; Chan DT; Watts GF; Chan DC; Ng TW; Dogra GK; Irish AB; Barrett PH
    J Lipid Res; 2011 Apr; 52(4):794-800. PubMed ID: 21297177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.